How a protein helps fold insulin-like growth factors
Mechanism by which the Grp94 molecular chaperone folds insulin-like growth factors
This study is looking at how a special helper protein called Grp94 works with another helper protein, BiP, to make sure insulin-like growth factors (IGFs) are properly prepared and released in the body, which is important for their function.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brandeis University NIH-funded |
| Lab location | 1 site (Waltham, United States) |
| Project ID | NIH-11085796 on NIH RePORTER |
What this research studies
This research investigates the role of the Grp94 molecular chaperone in the proper folding and secretion of insulin-like growth factors (IGFs). It explores how Grp94 interacts with another chaperone, BiP, to determine whether IGFs should be transferred for further processing or retained. By understanding this mechanism, the research aims to uncover the conditions that facilitate the transfer of IGFs from BiP to Grp94, which is crucial for their proper function. The study employs biophysical techniques to analyze the interactions and conformational changes involved in this process.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions influenced by insulin-like growth factors, particularly those with cancer.
Not a fit: Patients who do not have any conditions related to insulin-like growth factors or cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for conditions related to insulin-like growth factors, including certain cancers.
How similar studies have performed: Other research has shown promising results in understanding protein folding mechanisms, suggesting that this approach could yield valuable insights.
Where this research is happening
Waltham, United States
- Brandeis University — Waltham, United States (Active)
Researchers
- Principal investigator: Street, Timothy Oliver — Brandeis University
- Study coordinator: Street, Timothy Oliver
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.